Form 8-K - Current report:
SEC Accession No. 0001140361-20-004828
Filing Date
2020-03-04
Accepted
2020-03-04 17:08:23
Documents
14
Period of Report
2020-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 34719
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 7650
6 image0.jpg GRAPHIC 6710
  Complete submission text file 0001140361-20-004828.txt   192493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mgnx-20200227.xsd EX-101.SCH 4204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgnx-20200227_lab.xml EX-101.LAB 22718
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgnx-20200227_pre.xml EX-101.PRE 16222
7 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4070
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 20688222
SIC: 2834 Pharmaceutical Preparations